Alterity Therapeutics has outlined three priorities for 2026 following the successful completion in 2025 of a Phase II trial of ... Read More The post Alterity gears up for Phase III MSA trial, ...

Attention has turned to progressive supranuclear palsy, a rare neurodegenerative disorder. Here's what it is and why it's ...

As we get older, any number of things – from illness to medication, body confidence, relationship worries and family dynamics – can impact our sex lives.

ABLi Therapeutics (“ABLi”), a biotechnology company developing therapeutics to address diseases that arise from activation of Abelson Tyrosine Kinases (c-Abl kinases), announces publication of the ...

During the Boston Globe’s Rare Disease Summit, Dr. Wendy Chung, a physician-scientist and geneticist who leads the Department ...

In India, rare diseases are not so rare. It is estimated that around 70 million Indians live with one of more than 7,000 rare diseases, many of which are genetic […] ...

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.

EXCLUSIVE: Wolfgang Puck has dismissed Brooklyn Beckham as “not a chef,” as he savagely offered to teach him properly amid ...

Speaking exclusively to Irish Star, Rod Stewart's close friend and fellow rock star, Richard Marx, opened up about what it's like to party with the Forever Young singer ...

Q4 2025 Earnings Call February 18, 2026 3:30 AM ESTCompany ParticipantsGunilla Osswald - President & CEOJohanna Fälting ...

Lipocine Inc. , a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral delivery, today announced that the last patient has ...

It is an honor and a privilege to lead such a talented and committed team as Arvinas enters a period where we anticipate ...